article Fall 2021

Speeding up CRISPR’s Path from Benchtop to Bedside

In the last decade, headlines surrounding the therapeutic potential of CRISPR have been dazzling the public. This revolutionary gene-editing technique has ignited the hopes of healthcare professionals and patients alike in tackling genetic diseases. However, the question remains: who will benefit from CRISPR and how soon? The Somatic Cell Genome Editing (SCGE) Consortium sponsored by […]